Intermountain, Syapse Team on Clinical Genomics Service for Oncologists | GenomeWeb

NEW YORK (GenomeWeb) – Syapse and Intermountain Healthcare said today that they will collaborate to offer Intermountain's network of oncologists, tools for genomics-driven cancer care.

Intermountain is a non-profit system of 22 hospitals, 185 physician clinics, and an affiliated health insurance company. It selected Syape's software to provide oncologists with access to tumor genome profiling, data analysis, and drug procurement services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.